News
MDWD
14.11
+0.21%
0.03
After Smith+Nephew’s $34 Billion Merger Collapse, This Wound Care Stock Is Worth a Look (NASDAQ: MDWD)
TipRanks · 1d ago
Weekly Report: what happened at MDWD last week (1102-1106)?
Weekly Report · 2d ago
MediWound Ltd. Enters Underwriting Agreement for $17.25 million Public Offering
NASDAQ · 5d ago
MediWound Announces $17.25 Million Share Offering After Full Option Exercise
TipRanks · 5d ago
MediWound (MDWD) Moves 6.1% Higher: Will This Strength Last?
NASDAQ · 6d ago
MediWound Prices $15 Mln Offering Of Shares At $12.50 Per Share; Stock Down
NASDAQ · 11/04 02:42
MediWound announces $15M public offering of ordinary shares
Seeking Alpha · 11/03 21:47
MediWound Announces $15M Bought Deal Offering Of 1.2M Shares At $12.50/Share
Benzinga · 11/03 21:44
MediWound’s EscharEx Strategy May Be Ahead of the Game as FDA Puts Chronic Wounds in Focus (Nasdaq: MDWD)
TipRanks · 11/03 13:40
Madrigal (MDGL) Q3 Earnings and Revenues Beat Estimates
NASDAQ · 11/03 12:15
Weekly Report: what happened at MDWD last week (1026-1030)?
Weekly Report · 11/02 09:48
Weekly Report: what happened at MDWD last week (1019-1023)?
Weekly Report · 10/26 09:48
Weekly Report: what happened at MDWD last week (1012-1016)?
Weekly Report · 10/19 09:48
Weekly Report: what happened at MDWD last week (1005-1009)?
Weekly Report · 10/12 09:51
Weekly Report: what happened at MDWD last week (0928-1002)?
Weekly Report · 10/05 09:51
H.C. Wainwright Remains a Buy on Mediwound (MDWD)
TipRanks · 10/01 14:26
Weekly Report: what happened at MDWD last week (0921-0925)?
Weekly Report · 09/28 09:48
Analysts Are Bullish on These Healthcare Stocks: Mediwound (MDWD), BridgeBio Pharma (BBIO)
TipRanks · 09/24 11:30
Analysts’ Top Healthcare Picks: Ligand Pharma (LGND), Mediwound (MDWD)
TipRanks · 09/23 08:10
Why the Pentagon Keeps Funding This Small Cap (Nasdaq: MDWD)
TipRanks · 09/22 12:30
More
Webull provides a variety of real-time MDWD stock news. You can receive the latest news about Mediwound through multiple platforms. This information may help you make smarter investment decisions.
About MDWD
Mediwound Ltd is an Israel-based biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration. Company's portfolio is focused on next-generation protein-based therapies for burn and wound care and tissue repair and includes products such as, NexoBrid, a concentrate of proteolytic enzymes enriched in bromelain, which is an easy to use, topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues.; EscharEx biological drug candidate for the debridement of chronic and other hard-to-heal wounds; MW005 a topically applied biological drug candidate for the treatment of non-melanoma skin cancers, based on the same API of NexoBrid and EscharEx products, a concentrate of proteolytic enzymes enriched in bromelain.